Skip to main content

Mitigation of gastrointestinal acute radiation syndrome by promoting clusterin-mediated intestinal regeneration

OD - NIH Office of the Director

open
OpenLast verified: 2026-06-20

About This Grant

ABSTRACT The radiation tolerance of the gastrointestinal (GI) tract can be exceeded in radiation accidents or in the case of nuclear warfare, resulting in a lethal GI acute radiation syndrome (GI-ARS). There are no current FDA- approved medical countermeasures to mitigate GI-ARS; thus, there is an urgent need to identify key mechanisms of repair and regeneration in the irradiated intestinal epithelium. We have shown that the regeneration of the intestinal epithelium in response to severe radiation injury is mediated through revival stem cells (revSCs), which are generated through fetal-like reprogramming and identified by a marker gene Clusterin (Clu) (the mouse ortholog of human CLU). Remarkably, whole animal deletion of Clu significantly sensitizes mice to GI-ARS, while GI-ARS in mice is significantly mitigated via treatment with exogenous mouse Clu protein starting 24 hours post-irradiation. In addition, our preliminary data suggest that the cGAS-STING pathway acts as an upstream regulator of Clu in the irradiated intestinal epithelium. Treatment of mice with a STING agonist MSA-2 starting 24 hours after irradiation significantly improves the regeneration of irradiated small intestines. Thus, the overall goal of this proposal is to develop novel mitigators of the GI-ARS that promote the regeneration of irradiated intestinal epithelium by targeting the STING-CLU axis. In Aim 1, we will define the mechanisms by which CLU mitigates the development of GI-ARS. In Aim 2, we will dissect the STING-CLU axis in regulating the development of GI-ARS. Successful completion of the proposed study will demonstrate the key role of CLU in promoting the regeneration of the intestinal epithelium following acute radiation injury in mice and human intestinal organoids. We anticipate that our findings will significantly impact the successful development of GI-ARS mitigators that target the STING-CLU axis.

Grant Summary

Mitigation of gastrointestinal acute radiation syndrome by promoting clusterin-mediated intestinal regeneration is a OD - NIH Office of the Director grant providing up to $111K for university, nonprofit, healthcare org. Applications are due 2029-11-30 (open). Check eligibility and apply with FindGrants.

Not quite the right fit?

Search 9,000+ open grants, or get matches ranked for your organization — free.

Focus Areas

health research

Eligibility

universitynonprofithealthcare org

How to Apply

Funding Range

Up to $111K

Deadline

2029-11-30

Complexity
Medium
  1. 1Confirm your organization is eligible for Mitigation of gastrointestinal acute radiation syndrome by promoting clusterin-mediated intestinal regeneration from OD - NIH Office of the Director, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to OD - NIH Office of the Director before the deadline.
This record is a past award, contract, or funder profile — useful for research, but not an open grant application. Check the original source for current opportunities from this funder.

Don't want to draft it yourself?

We'll draft the complete application against OD - NIH Office of the Director's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

Mitigation of gastrointestinal acute radiation syndrome by promoting clusterin-mediated intestinal regeneration: Frequently Asked Questions

Who is eligible for the Mitigation of gastrointestinal acute radiation syndrome by promoting clusterin-mediated intestinal regeneration?

Mitigation of gastrointestinal acute radiation syndrome by promoting clusterin-mediated intestinal regeneration is offered by OD - NIH Office of the Director and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the Mitigation of gastrointestinal acute radiation syndrome by promoting clusterin-mediated intestinal regeneration provide?

Mitigation of gastrointestinal acute radiation syndrome by promoting clusterin-mediated intestinal regeneration provides up to $111K per award from OD - NIH Office of the Director. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the Mitigation of gastrointestinal acute radiation syndrome by promoting clusterin-mediated intestinal regeneration deadline?

Applications for Mitigation of gastrointestinal acute radiation syndrome by promoting clusterin-mediated intestinal regeneration are due 2029-11-30 (open). Because deadlines can change, verify the date with the funder, OD - NIH Office of the Director, and give yourself enough time to prepare a complete, competitive application before the close date.

How do you apply for the Mitigation of gastrointestinal acute radiation syndrome by promoting clusterin-mediated intestinal regeneration?

To apply for Mitigation of gastrointestinal acute radiation syndrome by promoting clusterin-mediated intestinal regeneration, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from OD - NIH Office of the Director.